Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide Challenge in Aneurysmal Subarachnoid Hemorrhage
NCT03377049Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jul 2019
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in cerebral vasospasm, sponsored by University of Wisconsin–Madison. Started Jul 2019; status: completed.
02
Drugs
acetazolamide
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT03377049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03377049.